Excellence in education and training advances competitiveness of the pharmaceutical industry in Europe

Research output: Contribution to journalComment/debateResearch

Standard

Excellence in education and training advances competitiveness of the pharmaceutical industry in Europe. / Bjerrum, Ole Jannik.

In: European Journal of Pharmaceutical Sciences, Vol. 44, No. 2, 2011, p. 174-175.

Research output: Contribution to journalComment/debateResearch

Harvard

Bjerrum, OJ 2011, 'Excellence in education and training advances competitiveness of the pharmaceutical industry in Europe', European Journal of Pharmaceutical Sciences, vol. 44, no. 2, pp. 174-175. https://doi.org/10.1016/j.ejps.2011.07.006

APA

Bjerrum, O. J. (2011). Excellence in education and training advances competitiveness of the pharmaceutical industry in Europe. European Journal of Pharmaceutical Sciences, 44(2), 174-175. https://doi.org/10.1016/j.ejps.2011.07.006

Vancouver

Bjerrum OJ. Excellence in education and training advances competitiveness of the pharmaceutical industry in Europe. European Journal of Pharmaceutical Sciences. 2011;44(2):174-175. https://doi.org/10.1016/j.ejps.2011.07.006

Author

Bjerrum, Ole Jannik. / Excellence in education and training advances competitiveness of the pharmaceutical industry in Europe. In: European Journal of Pharmaceutical Sciences. 2011 ; Vol. 44, No. 2. pp. 174-175.

Bibtex

@article{03f9d996e25b4043afa05c1c5e2c569b,
title = "Excellence in education and training advances competitiveness of the pharmaceutical industry in Europe",
author = "Bjerrum, {Ole Jannik}",
year = "2011",
doi = "10.1016/j.ejps.2011.07.006",
language = "English",
volume = "44",
pages = "174--175",
journal = "Norvegica Pharmaceutica Acta",
issn = "0928-0987",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - Excellence in education and training advances competitiveness of the pharmaceutical industry in Europe

AU - Bjerrum, Ole Jannik

PY - 2011

Y1 - 2011

U2 - 10.1016/j.ejps.2011.07.006

DO - 10.1016/j.ejps.2011.07.006

M3 - Comment/debate

C2 - 21782938

VL - 44

SP - 174

EP - 175

JO - Norvegica Pharmaceutica Acta

JF - Norvegica Pharmaceutica Acta

SN - 0928-0987

IS - 2

ER -

ID: 38275187